MedPath
NMPA Approval

Brimonidine Tartrate Eye Drops

国药准字H20254308

May 27, 2025

Drug Information

酒石酸溴莫尼定滴眼液

眼用制剂

0.2%(5ml:10mg)

化学药品

May 27, 2025

Company Information

Applicant Company

浙江省杭州市钱塘区下沙街道银海科创中心20幢101室

Manufacturing Company

浙江省金华市婺城区汤溪镇永湖街788号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酒石酸溴莫尼定滴眼液 - NMPA 批准文号 | MedPath